We Think Bioceltix (WSE:BCX) Can Afford To Drive Business Growth
Dec 11
Have your own idea? Try our Stock Screener
Polish (WIG) Biotech Industry Analysis
UpdatedJan 14, 2026
DataAggregated Company Financials
Companies13
- 7D3.0%
- 3M7.3%
- 1Y4.3%
- YTD6.1%
The Biotech industry has gained 2.5% in the last week and Bioceltix up 3.0%. Overall in the last year, the industry is flat. Earnings are forecast to grow by 57% annually.
Industry Valuation and Performance
Has the Polish Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Wed, 14 Jan 2026 | zł2.0b | zł427.5m | -zł155,672,238.00 | 45.9x | -13x | 4.7x |
| Fri, 12 Dec 2025 | zł1.8b | zł427.5m | -zł155,678,193.00 | 47.4x | -11.8x | 4.3x |
| Sun, 09 Nov 2025 | zł1.9b | zł425.3m | -zł159,129,765.00 | 51.8x | -11.9x | 4.4x |
| Tue, 07 Oct 2025 | zł2.0b | zł394.5m | -zł169,922,766.00 | 40.7x | -11.5x | 5x |
| Thu, 04 Sep 2025 | zł2.0b | zł403.5m | -zł140,003,812.00 | 44.2x | -13.9x | 4.8x |
| Sat, 02 Aug 2025 | zł2.1b | zł401.8m | -zł140,766,468.00 | 31.6x | -14.6x | 5.1x |
| Mon, 30 Jun 2025 | zł2.0b | zł401.8m | -zł140,766,468.00 | 32.2x | -14.2x | 5x |
| Wed, 28 May 2025 | zł2.1b | zł428.5m | -zł110,921,634.00 | 52.2x | -18.9x | 4.9x |
| Fri, 25 Apr 2025 | zł2.0b | zł438.6m | -zł95,762,193.00 | 28.6x | -20.8x | 4.5x |
| Sun, 23 Mar 2025 | zł2.0b | zł438.8m | -zł95,426,193.00 | 31x | -20.9x | 4.5x |
| Tue, 18 Feb 2025 | zł2.1b | zł438.8m | -zł94,289,269.00 | 42.2x | -21.8x | 4.7x |
| Thu, 16 Jan 2025 | zł1.9b | zł408.7m | -zł84,434,269.00 | 42.8x | -22.6x | 4.7x |
| Sat, 14 Dec 2024 | zł1.9b | zł408.7m | -zł84,434,269.00 | 38.3x | -22.3x | 4.6x |
| Mon, 11 Nov 2024 | zł2.1b | zł401.6m | -zł85,417,969.00 | 58.8x | -24.1x | 5.1x |
| Wed, 09 Oct 2024 | zł2.1b | zł438.7m | -zł64,845,969.00 | 62.4x | -33.1x | 4.9x |
| Fri, 06 Sep 2024 | zł2.2b | zł446.6m | -zł67,609,784.00 | 65.1x | -32.1x | 4.9x |
| Sun, 04 Aug 2024 | zł2.2b | zł444.2m | -zł64,230,755.00 | 71.5x | -33.6x | 4.9x |
| Tue, 02 Jul 2024 | zł2.0b | zł444.2m | -zł64,230,755.00 | 71x | -31.7x | 4.6x |
| Thu, 30 May 2024 | zł2.2b | zł439.7m | -zł97,717,228.00 | 71x | -22.6x | 5x |
| Sat, 27 Apr 2024 | zł2.3b | zł441.3m | -zł93,380,007.00 | 56x | -24.1x | 5.1x |
| Mon, 25 Mar 2024 | zł2.2b | zł462.1m | -zł74,341,007.00 | 58.9x | -29.1x | 4.7x |
| Wed, 21 Feb 2024 | zł2.4b | zł462.1m | -zł74,341,007.00 | 60.1x | -31.7x | 5.1x |
| Fri, 19 Jan 2024 | zł2.7b | zł499.9m | -zł66,755,911.00 | 88.7x | -40.5x | 5.4x |
| Sun, 17 Dec 2023 | zł2.8b | zł499.9m | -zł66,755,911.00 | 93.3x | -41.6x | 5.6x |
| Tue, 14 Nov 2023 | zł2.6b | zł511.7m | -zł63,340,678.00 | 45.7x | -40.9x | 5.1x |
| Thu, 12 Oct 2023 | zł2.7b | zł518.4m | -zł60,859,678.00 | 49.6x | -43.9x | 5.2x |
| Sat, 09 Sep 2023 | zł2.9b | zł522.2m | -zł66,814,668.00 | 49.6x | -42.7x | 5.5x |
| Mon, 07 Aug 2023 | zł2.8b | zł520.7m | -zł42,515,291.00 | 51.6x | -66.8x | 5.5x |
| Wed, 05 Jul 2023 | zł2.8b | zł520.7m | -zł42,515,291.00 | 53.6x | -66.7x | 5.4x |
| Fri, 02 Jun 2023 | zł2.8b | zł515.9m | -zł50,000,721.00 | 62.7x | -56.7x | 5.5x |
| Sun, 30 Apr 2023 | zł2.9b | zł536.5m | -zł32,904,449.00 | 68.2x | -89.3x | 5.5x |
| Tue, 28 Mar 2023 | zł2.7b | zł488.3m | -zł16,018,449.00 | 56.5x | -166.6x | 5.5x |
| Thu, 23 Feb 2023 | zł3.0b | zł488.6m | -zł16,165,349.00 | 66.9x | -183.2x | 6.1x |
| Sat, 21 Jan 2023 | zł3.0b | zł496.5m | -zł10,783,764.00 | 47.8x | -275x | 6x |
Price to Earnings Ratio
-275x
Current Industry PE
- Investors are relatively neutral on the Polish Biotechs industry at the moment, indicating that they anticipate long term growth rates to remain steady.
- The industry is trading close to its 3-year average PS ratio of 5.1x.
Past Earnings Growth
- The earnings for companies in the Biotechs industry have deteriorated over the last three years.
- Revenues have also declined 4.9% per year.
- This means overall sales from these companies are declining and losses are subsequently expanding as well.
Industry Trends
Which industries have driven the changes within the Polish Healthcare industry?
| PL Market | 0.97% | |
| Healthcare | 4.81% | |
| Biotech | 3.01% | |
| Biotech | 3.01% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| BCX Bioceltix | zł82.60 | 3.0% +zł11.8m | -2.0% | PB15.1x | |
| CTX Captor Therapeutics Spolka Akcyjna | zł82.00 | 2.5% +zł11.1m | 87.6% | PS59.9x | |
| MAB Mabion | zł8.50 | 7.7% +zł9.9m | -12.3% | PS9.3x | |
| SVE Synthaverse | zł4.16 | 3.2% +zł9.2m | -4.4% | PE66.2x | |
| PTG Poltreg | zł27.00 | 5.9% +zł7.0m | -29.9% | PB2.5x |